Published in Health Business Week, January 4th, 2008
"Indevus is firmly committed to providing continuity of care for current Viadur patients," stated Kurt W....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.